research funding database


Prevention of Alzheimer´s Disease Research Grant (worldwide)

Share this post

funding consultation boking
Free trial

The “Prevention Pipeline” from the Alzheimer´s Drug Discovery Foundation provides funding for studies, including clinical trials, that examine whether the use or choice of drugs affects dementia or cognitive decline in three main focus areas:

  • Studies of Cognitive Decline and Risk Reduction
  • Comparative Effectiveness Research
  • Studies Leveraging the Consortium of Cohorts for Alzheimer’s Prevention Action (CAPA)

Funding is available to researchers worldwide, at both non-profit research institutions as well as for-profit organizations. Applicants may apply for up to 5 million USD (direct costs only) for multi-year funding support. There are three assessment rounds per year.

The next letter of intent is due Mary 13, 2024, and the full application is due on July 22, 2024.

Adverts. Premium members do not see Google Ads.

Please Login / Subscribe to our premium membership to see the content. Sign up to Free trial to see detailed funding information.

non member

Sign-up for our monthly
research funding newsletter

you can unsubscribe at any time

Be the first to know

Sign-up for Personalized Grant Alerts